Latest Microba News

Biomedical grants set to bring new projects to Queensland
Microba Life Sciences announces results of successful Phase IBD trial
Microba completes stage one screening for its autoimmune disease program
AusBiotech 2023 underway in Queensland
It’s in our DNA: Australia’s biggest week in life sciences to advance biotech
AusBioInvest 2023 connects innovators with investment
AusBioInvest 2023 marks beginning of Australia’s biggest week in biotech
Top performing ASX life science companies 26 October
AusBioInvest 2023 programme launched
Save $350 with AusBiotech 2023 early-bird rates
AusBiotech 2023 programme launched
AusBiotech 2023 Millis Orator announced
QUT awarded $3M to build Australia’s first comprehensive human microbiome biobank
Fulbright Scholar investigates secret life of healthy gut
Microba Life Sciences announces new distribution agreements in Europe
Sonic Healthcare takes major strategic stake in Microba
New investor guide profiles biotech companies to watch
Linking biotech and investors: Stellar AusBioInvest 2022 programme launched
$1.4 million in grants to help Queensland exporters take off
Thriving medtech community celebrated at record-breaking AusMedtech 2022
Four QIMR Berghofer scientists awarded prestigious Fellowships
Microba announces new research partnership and senior appointment
$185 million investment to fast-track treatments for rare and ‘untreatable’ cancers
Defence awards $7 million for studies on gut health and wearable biomarker technology
Research investigates how gut wages war on brains of soldiers
Flipping gut microbiome-autism link on its head
Australia’s premier life sciences conferences celebrate and champion sector
CV-19 vaccine designer joins AusBiotech 2021 line-up
Microba co-founder and gut analysis expert to head microbiome research at QUT
Study investigates link between gut health and allergy in infants